Clinical Trials Logo

Filter by:
NCT ID: NCT05596461 Recruiting - Affective Disorder Clinical Trials

New Techniques for Diagnosis and Treatment of Cognitive Impairment in Affective Disorder

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the pathological mechanism of cognitive impairment in patients with affective disorder based on brain gut axis research, preliminarily verify the clinical efficacy of new neural regulation technology on cognitive impairment, and establish an evaluation model to predict the efficacy of physical therapy for affective disorder.

NCT ID: NCT05596435 Recruiting - Pancreatic Cancer Clinical Trials

Early Detection of Pancreatic Cancer

Start date: October 10, 2022
Phase:
Study type: Observational

The purpose of this study is to enable non-invasive early detection of pancreatic cancer in high-risk populations through the establishment of a machine learning model using plasma cell-free DNA fragmentomics. Plasma cell-free DNA from early stage pancreatic cancer patients and healthy individuals will be subjected to whole-genome sequencing. Features, such as cell-free DNA fragmentation, copy number variations and the status of KRAS gene mutation, will be assessed to generate this model.

NCT ID: NCT05596344 Recruiting - Depression Clinical Trials

Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

Start date: May 20, 2023
Phase:
Study type: Observational

This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

NCT ID: NCT05596279 Completed - Clinical trials for Coronary Artery Disease

PANOVISION: Feasibility and Safety of Hybrid IVUS-OCT System

Start date: November 20, 2019
Phase: N/A
Study type: Interventional

Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) were all recommended for percutaneous coronary intervention (PCI) optimization in the latest guidelines, however, which imaging modality was more suitable as either a diagnostic or guidance tool was still unknown. Recently, a novel, well-designed hybrid imaging system was approved for clinical use, allowing the accurate co-registration of two imaging modalities and immediate, simultaneous image review. For testing each modality in the hybrid imaging system, the investigators conducted this prospective, multicentre, non-inferiority trial. In this study, all participants achieved hybrid IVUS-OCT imaging after stenting, at meanwhile, patients randomly assigned to the IVUS arm were performed control IVUS (OptiCross, Boston Scientific, Natick, MA), and patients randomly assigned to the OCT arm were performed control OCT (C7 Dragonfly Duo, St. Jude Medical, St. Paul, MN). In this study, the investigators evaluated the non-inferiority of standalone IVUS versus control IVUS or standalone OCT versus control OCT in clinical feasibility using clear stent capture rate (CSCR) and safety using perioperative device-related adverse cardiovascular events.

NCT ID: NCT05596266 Recruiting - Clinical trials for T-cell Acute Lymphoblastic Leukemia

CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia

Start date: October 25, 2022
Phase: Phase 1
Study type: Interventional

This is a phase I, interventional, single arm, open label, clinical study to evaluate the safety and tolerability of CD5 CAR-T cells in refractory/relapsed CD5+ T-ALL patients who have no available curative treatment options.

NCT ID: NCT05596253 Recruiting - Heart Failure Clinical Trials

Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis

Start date: October 11, 2022
Phase:
Study type: Observational

The purpose of this study is to conduct a prospective trial to investigate the incidence of heart failure in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt ,and to analyze the the predictors and modififications of cardiac function.

NCT ID: NCT05596188 Recruiting - Prostate Cancer Clinical Trials

Anxiety Before Non-cardiac Surgery in Adults

Start date: November 10, 2022
Phase:
Study type: Observational [Patient Registry]

Adult patients undergoing elective non-cardiac surgery were enrolled. Anxiety before the operation was evaluated by The State Anxiety Inventory (S-AI). Logistics regression would be used for identifying the independent factors of preoperative anxiety and prediction model would be established.

NCT ID: NCT05596097 Not yet recruiting - Clinical trials for Diffuse Large B-cell Lymphoma (DLBCL)

Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

Start date: October 30, 2022
Phase: Phase 2
Study type: Interventional

This trial is a single-center, single-arm, prospective clinical study to investigate the efficacy and safety of zanubrutinib maintenance therapy in patients with diffuse large B-cell lymphoma (DLBCL) in Initial remission. The patients were divided into two categories: 1) Zanubrutinib maintenance therapy was started after R-CHOP induction and consolidation therapy reached maximum efficacy; 2) Initiate zanubrutinib maintenance therapy after maximal response to induction and consolidation therapy with or without rituximab (R-chemo). Therefore, the data in this study will reflect the efficacy and safety of zanubrutinib in the maintenance treatment of DLBCL patients with initial remission, and will provide new insights into the clinical application of zanubrutinib.

NCT ID: NCT05596071 Completed - Clinical trials for Postoperative Delirium

Whether Opioids Are Factor That Induced POD?

POD
Start date: June 25, 2016
Phase: N/A
Study type: Interventional

The purpose of this study was to investigate whether perioperative use of low doses of opioids could reduce postoperative delirium .

NCT ID: NCT05595967 Active, not recruiting - Clinical trials for Pelvic Floor Dysfunction

Community Based Health Education for Prevention of Pelvic Floor Dysfunction in Fertile Women in Rural China

Start date: August 18, 2022
Phase: N/A
Study type: Interventional

According to the experts in charge of the healthcare department in the Liangshan area, Liangshan is one of the largest Yi inhabited areas in China. Influenced by local culture and production history, most women there are multiparas, with more than one child, and their awareness of postpartum recovery is relatively weak. Therefore, the prevalence and incidence rate of pelvic floor dysfunction diseases is high in the Liangshan area. In addition, women in the Liangshan area shoulder the responsibility of taking care of family members, farmland, and livestock. They play an important role in family production, which guarantees the opportunity for other family members to go out to work. However, pelvic floor dysfunction can be manifested by persistent pelvic distension, frequent urination, the urgency of urination, difficulty in urination or defecation, and pain or difficulty in sexual intercourse, which decreases the quality of normal life, and the efficiency of production, posing many psychological problems and family contradictions. There is no research to prove the exact intervention measures that can effectively improve the pelvic floor function of women in Liangshan ethnic minority areas. This study aims to promote the formation of women's healthy living habits and behaviors, improve women's pelvic floor function, and then develop the quality of life and labor output of local women through intervention including health knowledge education and pelvic floor muscle exercise.